title: Pharmacokinetics and bioequivalence study of a generic desloratadine tablet formulation in healthy male volunteers.
abstract: The pharmacokinetic profiles and relative bioavailability of desloratadine (CAS 100643-71-8, Denosin as test and another commercially available preparation as reference) tablets from two different pharmaceutical manufacturers were carried out. A single oral dose (10 mg/2 tablets) of desloratadine was administered to 8 healthy young Chinese males in a completely double-blind cross-over design with a two-week washout period between each dose. Plasma samples were obtained before and at various appropriate intervals after dosing up to 120 h. The plasma concentrations were then analyzed by a liquid chromatography/tandem mass spectrometric (LC/MS/MS) method. The limit of quantitation of this LC/MS/MS method was 0.05 ng/mL. The coefficients of variation of the within-day and between-day calibration curves (n = 6) range from 0.05 ng/mL to 10 ng/mL and were less than 10%. The accuracy of this method was verified. Values for the area under the plasma concentration-time curve (AUC), peak concentration (Cmax), time to peak concentration (Tmax), elimination rate constant, half-life, oral clearance were estimated and compared for each preparation. By ANOVA, 90% confidence interval, Mann-Whitney test, and paired t-test, the two desloratadine products can be considered bioequivalent for both the extent and the rate of absorption.
authors.affiliation: Department of Pediatrics, Taipei Medical University Hospital and Graduate Institute of Medical Science, Taipei Medical University, Taipei, Taiwan, Republic of China.
authors.forename: Geng-Chang
authors.initials: GC
authors.lastname: Yeh
authors.forename: Shin-Tarng
authors.initials: ST
authors.lastname: Deng
authors.forename: Chin-Yi
authors.initials: CY
authors.lastname: Lo
authors.forename: Pei-Shan
authors.initials: PS
authors.lastname: Chiang
authors.forename: Cheng-Huei
authors.initials: CH
authors.lastname: Hsiong
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000493:pharmacokinetics*; D019540:Area Under Curve; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D006207:Half-Life; D006801:Humans; D017336:Loratadine / Q000493:pharmacokinetics*; D008297:Male; D013058:Mass Spectrometry; D013607:Tablets; D013810:Therapeutic Equivalency
chemical_list: D018926:Anti-Allergic Agents; D013607:Tablets; D017336:Loratadine